New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

31st January 2022

Home Category Drug Development FDA Approvals

FDA Approvals

Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

29th January 2022

Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for...

Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

by Content Team

29th January 2022

Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Australia's Therapeutic...

EC Approves Merck’s KEYTRUDA as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma Following Surgery

by Content Team

29th January 2022

EC Approves Merck's KEYTRUDA as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma Following Surgery

Merck, known as MSD outside the United States and Canada, announced that the EC has approved KEYTRUDA, Merck’s anti-PD-1 therapy,...

Cystic Fibrosis Treatment Approved By European Commission

by Content Team

17th January 2022

Cystic Fibrosis Treatment Approved By European Commission

There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in the UK...

New lung cancer treatment combo approved on NHS in England

by Content Team

17th January 2022

Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely...

Pfizer and BioNTech Receive U.S. FDA EUA of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older

by Content Team

8th January 2022

Pfizer, Moderna & AstraZeneca - Their COVID-19 vaccine comparison

Pfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the EUA of a booster dose of the...

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

by Content Team

14th December 2021

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Roche announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19...

CHMP Recommends EU Approval of Regeneron Antibody Cocktail to Treat and Prevent COVID-19

by Content Team

19th November 2021

CHMP Recommends EU Approval of Regeneron Antibody Cocktail to Treat and Prevent COVID-19

Regeneron Pharmaceuticals, Inc. announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted...